Approval · Notice of Compliance 30490 · 2023
CLINDAMYCIN: Notice of Compliance 30490
Issued April 6, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30490
- Date
- April 6, 2023
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Labelling update to match licensor
- Canadian reference product
- DALACIN C (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLINDAMYCIN | Not yet assigned | — |
Medicinal ingredients
- CLINDAMYCIN HCL 150 MG per CAP
- CLINDAMYCIN HCL 300 MG per CAP